Diana Salnikova

11PUBLICATIONS
36CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsProteins and peptidesAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 30, 2025
Secosteroid-2-Pyrazoline Hybrids: Design, Synthesis, Biological Evaluation and Development of Therapeutic Combinations Against ERα-Positive Breast Cancer Cells.

Alexey I Ilovaisky, Alexander M Scherbakov, Fedor B Bogdanov

|Apr 14, 2025
Novel N-(4,5,6,7-tetrahydrobenzisoxazol-4-yl)amides as HSP90 inhibitors: design, synthesis and biological evaluation.

Nastassia A Varabyeva, Alexander M Scherbakov, Diana I Salnikova

|Jul 19, 2024
Design and synthesis of phosphoryl-substituted steroidal pyridazines (Pho-STPYRs) as potent estrogen receptor alpha inhibitors: targeted treatment of hormone-dependent breast cancer cells.

Yulia Volkova, Alexander Scherbakov, Yaraslau Dzichenka

|May 24, 2024
Target Role of Monocytes as Key Cells of Innate Immunity in Rheumatoid Arthritis.

Diana I Salnikova, Nikita G Nikiforov, Anton Y Postnov

|Jan 23, 2024
Synthesis and Biological Evaluation of Chalconesulfonamides: En Route to Proapoptotic Agents with Antiestrogenic Potency.

Stepan K Krymov, Diana I Salnikova, Lyubov G Dezhenkova

|Aug 30, 2023
Exosomes are involved in the intercellular transfer of rapamycin resistance in the breast cancer cells.

Yuri Yu Shchegolev, Danila V Sorokin, Alexander M Scherbakov

Pageof 2

Frequent Collaborators

9 joint publications

Alexander Scherbakov

5 joint publications

Fedor Bogdanov

3 joint publications

Danila V Sorokin

3 joint publications

Alvina I Khamidullina